AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Vitrafy Life Sciences Ltd

3.410

+0.0300.89%

Volume:46.08K

Turnover:152.28K

Market Cap:259.70M

PE:-13.54

High:3.410

Open:3.360

Low:3.250

Close:3.380

52wk High:4.660

52wk Low:1.160

Shares:76.16M

Float Shares:33.74M

Volume Ratio:1.26

T/O Rate:0.14%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.252

EPS(LYR):-0.252

ROE:-46.29%

ROA:-27.94%

PB:6.32

PE(LYR):-13.54

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Australia's Vitrafy Life Sciences Gains on Entering US Market

Vitrafy Life Sciences Ltd - Enters U.S. Cell & Gene Therapy Market with Charter Medical Agreement

THOMSON REUTERS

Vitrafy Life Sciences Posts FY Operating Loss of A$14.6 Million

Vitrafy Life Sciences Ltd - FY Operating Loss A$14.6 Mln

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/VFY.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"VFY.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"VFY.AU\",,,,,undefined,":{"symbol":"VFY.AU","market":"AU","secType":"STK","nameCN":"Vitrafy Life Sciences Ltd","latestPrice":3.41,"timestamp":1789539120000,"preClose":3.38,"halted":0,"volume":46077,"delay":0,"changeRate":0.008875739644970487,"nameEN":"Vitrafy Life Sciences Ltd","floatShares":33735952,"shares":76157278,"eps":-0.2518,"marketStatus":"Not Yet Opened","change":0.03,"latestTime":"09-16 16:12:00 AEST","open":3.36,"high":3.41,"low":3.25,"amount":152283,"amplitude":0.047337,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.2518,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":3.38,"openAndCloseTimeList":[[1789516800000,1789538400000]],"volumeRatio":1.2568602688758892,"lotSize":0,"tradeCurrency":"AUD","auctionPricing":{"symbol":"VFY.AU","preClose":3.38,"auctionPrice":3.41,"auctionVolume":30,"auction":3,"marketStatus":"盘后竞价","timestamp":1789538992531}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"VFY.AU\",,,,,undefined,":{"symbol":"VFY.AU","floatShares":33735952,"roa":"-27.94%","roe":"-46.29%","lyrEps":-0.2518,"volumeRatio":1.2568602688758892,"shares":76157278,"dividePrice":0,"high":3.41,"amplitude":0.047337,"preClose":3.38,"low":3.25,"week52Low":1.16,"pbRate":"6.32","psRate":"1242.58","week52High":4.66,"institutionHeld":0,"latestPrice":3.41,"eps":-0.2518,"divideRate":0,"volume":46077,"delay":0,"ttmEps":-0.2518,"open":3.36,"prevYearClose":1.28,"prevWeekClose":3.55,"prevMonthClose":3.85,"prevQuarterClose":3.01,"fiveDayClose":3.79,"twentyDayClose":4.33,"sixtyDayClose":3.08},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VFY.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-04","symbol":"VFY.AU","type":"earning","reportTimeType":"pre","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1785801600000,"name":null,"time":"Pre-MKt","dateTimestamp":1785765600000,"actualEps":null},{"date":"2026-04-28","symbol":"VFY.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1777334400000,"name":null,"time":"","dateTimestamp":1777298400000,"actualEps":null},{"date":"2026-02-03","symbol":"VFY.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770073200000,"name":null,"time":"","dateTimestamp":1770037200000,"actualEps":null},{"date":"2025-10-21","symbol":"VFY.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761001200000,"name":null,"time":"","dateTimestamp":1760965200000,"actualEps":null},{"date":"2025-08-05","symbol":"VFY.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1754352000000,"name":null,"time":"","dateTimestamp":1754316000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VFY.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VFY.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664893380","title":"Australia's Vitrafy Life Sciences Gains on Entering US Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2664893380","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664893380?lang=en_us&edition=fundamental","pubTime":"2026-09-02 11:10","pubTimestamp":1788318627,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Vitrafy Life Sciences gains on entering US market** Shares of Australia's Vitrafy Life SciencesVFY.AXrise as much as 6.7% to A$4.110, hitting their highest level since August 24** Cel","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL4N44U09J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VFY.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664886441","title":"Vitrafy Life Sciences Ltd - Enters U.S. Cell & Gene Therapy Market with Charter Medical Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2664886441","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664886441?lang=en_us&edition=fundamental","pubTime":"2026-09-02 07:17","pubTimestamp":1788304672,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T15V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","VFY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656852125","title":"Vitrafy Life Sciences Posts FY Operating Loss of A$14.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2656852125","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656852125?lang=en_us&edition=fundamental","pubTime":"2026-08-04 09:26","pubTimestamp":1785806787,"startTime":"0","endTime":"0","summary":"BRIEF-Vitrafy Life Sciences Posts FY Operating Loss Of A$14.6 MillionAug 4 (Reuters)-Vitrafy Life Sciences LtdVFY.AX:FY OPERATING LOSS A$14.6 MILLIONFurther company coverage:VFY.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN4401MC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","VFY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656557300","title":"Vitrafy Life Sciences Ltd - FY Operating Loss A$14.6 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2656557300","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656557300?lang=en_us&edition=fundamental","pubTime":"2026-08-04 06:24","pubTimestamp":1785795887,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN4401MC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VFY.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/VFY.AU\",params:#limit:6,delay:true,,,undefined,":[]}}